Post-approval Follow-up Study of the IC-8 Apthera Intraocular Lens (IOL)

CompletedOBSERVATIONAL
Enrollment

196

Participants

Timeline

Start Date

January 12, 2023

Primary Completion Date

February 16, 2024

Study Completion Date

February 16, 2024

Conditions
CataractPresbyopia
Trial Locations (20)

12603

Alterman, Modi & Wolter, Poughkeepsie

18702

Bucci Laser Vision, Wilkes-Barre

19148

Philadelphia Eye Associates, Philadelphia

23502

Virginia Eye Consultants, Norfolk

27408

Physicians Protocol, Greensboro

44141

Cleveland Eye Clinic, Brecksville

55420

Chu Vision Institute, Bloomington

57108

Vance Thompson Vision, Sioux Falls

63128

Pepose Vision Institute, St Louis

68118

Kugler Vision, Omaha

77030

Baylor College of Medicine, Houston

78229

Parkhurst NuVision, San Antonio

80525

Eye Center of Northern Colorado, Fort Collins

84021

Hoopes Vision, Draper

84403

Utah Eye Centers, Ogden

85704

Fishkind, Bakewell, Maltzman, Hunter & Associates Eye Care & Surgery Center, Tucson

90067

Advanced Vision Care, Los Angeles

92653

Harvard Eye Associates, Laguna Hills

93309

Empire Eye & Laser Center, Bakersfield

94024

Altos Eye Physicians, Los Altos

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AcuFocus, Inc.

INDUSTRY

NCT05758883 - Post-approval Follow-up Study of the IC-8 Apthera Intraocular Lens (IOL) | Biotech Hunter | Biotech Hunter